INTERNATIONAL IMMUNOPHARMACOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2120704, encodeId=32302120e0483, content=2023-03-03投稿 03-06 with editor 03-09 under review 03-15 under review 后续有进展再来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=35, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/7xB3OdNLiaPjMD3qablwtib0m6Cckoj1K7cJkOI6CTrDh9Epco1zYLOtzs7icSgITEtJucVKNxnNLF34qG5GyxoZQ/0, createdBy=e71e2167526, createdName=ms9833658896231706, createdTime=Tue Mar 21 08:40:11 CST 2023, time=2023-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2190285, encodeId=137b21902856d, content=12月30号返修回去，投稿链接1月27显示的2个审稿人已经完成审稿，但是到今天系统一直是RRC，咋办呀？能催编辑吗？我感觉编辑都忘记了。。。太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d9892565543, createdName=12570e4cm50暂无昵称, createdTime=Fri Mar 01 08:18:28 CST 2024, time=2024-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189811, encodeId=4f6f218981181, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：炎症;巨噬细胞;骨科 经验分享：三个审稿人，每个审稿人8-10条意见，非常专业，效率很高，三个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8a02458802, createdName=12411d2dm22暂无昵称, createdTime=Wed Feb 28 09:19:40 CST 2024, time=2024-02-28, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2170197, encodeId=1dd921e019749, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：10.05投稿 10.11送审 10.26审稿人完成审稿 10.31给出大修 11.05修回 11.15审稿人完成审稿 11.16接收 11.19清样 10.22在线发表来还愿啦！效率很高的一个杂志，编辑和两位审稿人都很友好。修改后文章整体水平提升很大。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YConHRH5GCtcFEWO7xCkB10VsePH8PlzvattQoVRIQ7KJg26g6PvbkD8nE6Gsic5Nub2HzA4TsvkTQqEYUoz7pw/132, createdBy=288f2160779, createdName=liyu5975, createdTime=Wed Nov 22 11:16:56 CST 2023, time=2023-11-22, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2194365, encodeId=4820219436502, content=审稿速度:1.0 经验分享：审稿人意见“请修改文本格式，必要时使用连字符，使文章布局更加整洁易读”，这是什么意思？求指点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=884b6159465, createdName=ms5000000335651495, createdTime=Wed Mar 20 22:39:15 CST 2024, time=2024-03-20, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2194329, encodeId=c62d21943297a, content=大家知道自己的编辑是谁吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65878460096, createdName=ms9000002114823480, createdTime=Wed Mar 20 17:21:49 CST 2024, time=2024-03-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2194400, encodeId=4fed219440008, content=<a href='/topic/show?id=0d6a159920a' target=_blank style='color:#2F92EE;'>#SCI#</a>Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15992, encryptionId=0d6a159920a, topicName=SCI)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Thu Mar 21 09:05:46 CST 2024, time=2024-03-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2186259, encodeId=31eb21862594e, content=偏重的研究方向：免疫;药理学;炎症 经验分享：12.16日投稿，隔天under review，12.30第一个审稿人审回，一直到今天都木找到第二个审稿人……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04fe5219567, createdName=14778916m81暂无昵称, createdTime=Tue Feb 06 21:11:26 CST 2024, time=2024-02-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2159939, encodeId=cf6b215993935, content=9.22投稿，9.24 under review，邀请了9个审稿人，到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd58097633, createdName=ms8000001070008739, createdTime=Wed Sep 27 01:50:27 CST 2023, time=2023-09-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2182438, encodeId=a56c21824388d, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：胃癌;肿瘤免疫 经验分享：这个杂志真的好慢好慢，外审一个月，大修一个月，修回with editor一整个月，然后又送外审，十几天，RRC两周了，还没消息，等的我花都谢了。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Thu Jan 18 15:39:11 CST 2024, time=2024-01-18, status=1, ipAttribution=香港)]

2023-03-21 ms9833658896231706 来自江苏省

2023-03-03投稿
03-06 with editor
03-09 under review
03-15 under review
后续有进展再来。

52 35

展开35条回复

[GetPortalCommentsPageByObjectIdResponse(id=2120704, encodeId=32302120e0483, content=2023-03-03投稿 03-06 with editor 03-09 under review 03-15 under review 后续有进展再来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=35, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/7xB3OdNLiaPjMD3qablwtib0m6Cckoj1K7cJkOI6CTrDh9Epco1zYLOtzs7icSgITEtJucVKNxnNLF34qG5GyxoZQ/0, createdBy=e71e2167526, createdName=ms9833658896231706, createdTime=Tue Mar 21 08:40:11 CST 2023, time=2023-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2190285, encodeId=137b21902856d, content=12月30号返修回去，投稿链接1月27显示的2个审稿人已经完成审稿，但是到今天系统一直是RRC，咋办呀？能催编辑吗？我感觉编辑都忘记了。。。太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d9892565543, createdName=12570e4cm50暂无昵称, createdTime=Fri Mar 01 08:18:28 CST 2024, time=2024-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189811, encodeId=4f6f218981181, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：炎症;巨噬细胞;骨科 经验分享：三个审稿人，每个审稿人8-10条意见，非常专业，效率很高，三个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8a02458802, createdName=12411d2dm22暂无昵称, createdTime=Wed Feb 28 09:19:40 CST 2024, time=2024-02-28, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2170197, encodeId=1dd921e019749, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：10.05投稿 10.11送审 10.26审稿人完成审稿 10.31给出大修 11.05修回 11.15审稿人完成审稿 11.16接收 11.19清样 10.22在线发表来还愿啦！效率很高的一个杂志，编辑和两位审稿人都很友好。修改后文章整体水平提升很大。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YConHRH5GCtcFEWO7xCkB10VsePH8PlzvattQoVRIQ7KJg26g6PvbkD8nE6Gsic5Nub2HzA4TsvkTQqEYUoz7pw/132, createdBy=288f2160779, createdName=liyu5975, createdTime=Wed Nov 22 11:16:56 CST 2023, time=2023-11-22, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2194365, encodeId=4820219436502, content=审稿速度:1.0 经验分享：审稿人意见“请修改文本格式，必要时使用连字符，使文章布局更加整洁易读”，这是什么意思？求指点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=884b6159465, createdName=ms5000000335651495, createdTime=Wed Mar 20 22:39:15 CST 2024, time=2024-03-20, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2194329, encodeId=c62d21943297a, content=大家知道自己的编辑是谁吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65878460096, createdName=ms9000002114823480, createdTime=Wed Mar 20 17:21:49 CST 2024, time=2024-03-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2194400, encodeId=4fed219440008, content=<a href='/topic/show?id=0d6a159920a' target=_blank style='color:#2F92EE;'>#SCI#</a>Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15992, encryptionId=0d6a159920a, topicName=SCI)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Thu Mar 21 09:05:46 CST 2024, time=2024-03-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2186259, encodeId=31eb21862594e, content=偏重的研究方向：免疫;药理学;炎症 经验分享：12.16日投稿，隔天under review，12.30第一个审稿人审回，一直到今天都木找到第二个审稿人……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04fe5219567, createdName=14778916m81暂无昵称, createdTime=Tue Feb 06 21:11:26 CST 2024, time=2024-02-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2159939, encodeId=cf6b215993935, content=9.22投稿，9.24 under review，邀请了9个审稿人，到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd58097633, createdName=ms8000001070008739, createdTime=Wed Sep 27 01:50:27 CST 2023, time=2023-09-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2182438, encodeId=a56c21824388d, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：胃癌;肿瘤免疫 经验分享：这个杂志真的好慢好慢，外审一个月，大修一个月，修回with editor一整个月，然后又送外审，十几天，RRC两周了，还没消息，等的我花都谢了。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Thu Jan 18 15:39:11 CST 2024, time=2024-01-18, status=1, ipAttribution=香港)]

2024-03-01 12570e4cm50暂无昵称

12月30号返修回去，投稿链接1月27显示的2个审稿人已经完成审稿，但是到今天系统一直是RRC，咋办呀？能催编辑吗？我感觉编辑都忘记了。。。太难了

11 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2120704, encodeId=32302120e0483, content=2023-03-03投稿 03-06 with editor 03-09 under review 03-15 under review 后续有进展再来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=35, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/7xB3OdNLiaPjMD3qablwtib0m6Cckoj1K7cJkOI6CTrDh9Epco1zYLOtzs7icSgITEtJucVKNxnNLF34qG5GyxoZQ/0, createdBy=e71e2167526, createdName=ms9833658896231706, createdTime=Tue Mar 21 08:40:11 CST 2023, time=2023-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2190285, encodeId=137b21902856d, content=12月30号返修回去，投稿链接1月27显示的2个审稿人已经完成审稿，但是到今天系统一直是RRC，咋办呀？能催编辑吗？我感觉编辑都忘记了。。。太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d9892565543, createdName=12570e4cm50暂无昵称, createdTime=Fri Mar 01 08:18:28 CST 2024, time=2024-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189811, encodeId=4f6f218981181, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：炎症;巨噬细胞;骨科 经验分享：三个审稿人，每个审稿人8-10条意见，非常专业，效率很高，三个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8a02458802, createdName=12411d2dm22暂无昵称, createdTime=Wed Feb 28 09:19:40 CST 2024, time=2024-02-28, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2170197, encodeId=1dd921e019749, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：10.05投稿 10.11送审 10.26审稿人完成审稿 10.31给出大修 11.05修回 11.15审稿人完成审稿 11.16接收 11.19清样 10.22在线发表来还愿啦！效率很高的一个杂志，编辑和两位审稿人都很友好。修改后文章整体水平提升很大。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YConHRH5GCtcFEWO7xCkB10VsePH8PlzvattQoVRIQ7KJg26g6PvbkD8nE6Gsic5Nub2HzA4TsvkTQqEYUoz7pw/132, createdBy=288f2160779, createdName=liyu5975, createdTime=Wed Nov 22 11:16:56 CST 2023, time=2023-11-22, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2194365, encodeId=4820219436502, content=审稿速度:1.0 经验分享：审稿人意见“请修改文本格式，必要时使用连字符，使文章布局更加整洁易读”，这是什么意思？求指点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=884b6159465, createdName=ms5000000335651495, createdTime=Wed Mar 20 22:39:15 CST 2024, time=2024-03-20, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2194329, encodeId=c62d21943297a, content=大家知道自己的编辑是谁吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65878460096, createdName=ms9000002114823480, createdTime=Wed Mar 20 17:21:49 CST 2024, time=2024-03-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2194400, encodeId=4fed219440008, content=<a href='/topic/show?id=0d6a159920a' target=_blank style='color:#2F92EE;'>#SCI#</a>Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15992, encryptionId=0d6a159920a, topicName=SCI)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Thu Mar 21 09:05:46 CST 2024, time=2024-03-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2186259, encodeId=31eb21862594e, content=偏重的研究方向：免疫;药理学;炎症 经验分享：12.16日投稿，隔天under review，12.30第一个审稿人审回，一直到今天都木找到第二个审稿人……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04fe5219567, createdName=14778916m81暂无昵称, createdTime=Tue Feb 06 21:11:26 CST 2024, time=2024-02-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2159939, encodeId=cf6b215993935, content=9.22投稿，9.24 under review，邀请了9个审稿人，到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd58097633, createdName=ms8000001070008739, createdTime=Wed Sep 27 01:50:27 CST 2023, time=2023-09-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2182438, encodeId=a56c21824388d, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：胃癌;肿瘤免疫 经验分享：这个杂志真的好慢好慢，外审一个月，大修一个月，修回with editor一整个月，然后又送外审，十几天，RRC两周了，还没消息，等的我花都谢了。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Thu Jan 18 15:39:11 CST 2024, time=2024-01-18, status=1, ipAttribution=香港)]

2024-02-28 12411d2dm22暂无昵称来自河北省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：炎症;巨噬细胞;骨科
经验分享：三个审稿人，每个审稿人8-10条意见，非常专业，效率很高，三个月接收

12 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2120704, encodeId=32302120e0483, content=2023-03-03投稿 03-06 with editor 03-09 under review 03-15 under review 后续有进展再来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=35, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/7xB3OdNLiaPjMD3qablwtib0m6Cckoj1K7cJkOI6CTrDh9Epco1zYLOtzs7icSgITEtJucVKNxnNLF34qG5GyxoZQ/0, createdBy=e71e2167526, createdName=ms9833658896231706, createdTime=Tue Mar 21 08:40:11 CST 2023, time=2023-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2190285, encodeId=137b21902856d, content=12月30号返修回去，投稿链接1月27显示的2个审稿人已经完成审稿，但是到今天系统一直是RRC，咋办呀？能催编辑吗？我感觉编辑都忘记了。。。太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d9892565543, createdName=12570e4cm50暂无昵称, createdTime=Fri Mar 01 08:18:28 CST 2024, time=2024-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189811, encodeId=4f6f218981181, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：炎症;巨噬细胞;骨科 经验分享：三个审稿人，每个审稿人8-10条意见，非常专业，效率很高，三个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8a02458802, createdName=12411d2dm22暂无昵称, createdTime=Wed Feb 28 09:19:40 CST 2024, time=2024-02-28, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2170197, encodeId=1dd921e019749, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：10.05投稿 10.11送审 10.26审稿人完成审稿 10.31给出大修 11.05修回 11.15审稿人完成审稿 11.16接收 11.19清样 10.22在线发表来还愿啦！效率很高的一个杂志，编辑和两位审稿人都很友好。修改后文章整体水平提升很大。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YConHRH5GCtcFEWO7xCkB10VsePH8PlzvattQoVRIQ7KJg26g6PvbkD8nE6Gsic5Nub2HzA4TsvkTQqEYUoz7pw/132, createdBy=288f2160779, createdName=liyu5975, createdTime=Wed Nov 22 11:16:56 CST 2023, time=2023-11-22, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2194365, encodeId=4820219436502, content=审稿速度:1.0 经验分享：审稿人意见“请修改文本格式，必要时使用连字符，使文章布局更加整洁易读”，这是什么意思？求指点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=884b6159465, createdName=ms5000000335651495, createdTime=Wed Mar 20 22:39:15 CST 2024, time=2024-03-20, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2194329, encodeId=c62d21943297a, content=大家知道自己的编辑是谁吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65878460096, createdName=ms9000002114823480, createdTime=Wed Mar 20 17:21:49 CST 2024, time=2024-03-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2194400, encodeId=4fed219440008, content=<a href='/topic/show?id=0d6a159920a' target=_blank style='color:#2F92EE;'>#SCI#</a>Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15992, encryptionId=0d6a159920a, topicName=SCI)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Thu Mar 21 09:05:46 CST 2024, time=2024-03-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2186259, encodeId=31eb21862594e, content=偏重的研究方向：免疫;药理学;炎症 经验分享：12.16日投稿，隔天under review，12.30第一个审稿人审回，一直到今天都木找到第二个审稿人……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04fe5219567, createdName=14778916m81暂无昵称, createdTime=Tue Feb 06 21:11:26 CST 2024, time=2024-02-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2159939, encodeId=cf6b215993935, content=9.22投稿，9.24 under review，邀请了9个审稿人，到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd58097633, createdName=ms8000001070008739, createdTime=Wed Sep 27 01:50:27 CST 2023, time=2023-09-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2182438, encodeId=a56c21824388d, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：胃癌;肿瘤免疫 经验分享：这个杂志真的好慢好慢，外审一个月，大修一个月，修回with editor一整个月，然后又送外审，十几天，RRC两周了，还没消息，等的我花都谢了。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Thu Jan 18 15:39:11 CST 2024, time=2024-01-18, status=1, ipAttribution=香港)]

2023-11-22 liyu5975 来自陕西省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：免疫;炎症
经验分享：10.05投稿 10.11送审 10.26审稿人完成审稿 10.31给出大修 11.05修回 11.15审稿人完成审稿 11.16接收 11.19清样 10.22在线发表来还愿啦！效率很高的一个杂志，编辑和两位审稿人都很友好。修改后文章整体水平提升很大。

26 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2120704, encodeId=32302120e0483, content=2023-03-03投稿 03-06 with editor 03-09 under review 03-15 under review 后续有进展再来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=35, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/7xB3OdNLiaPjMD3qablwtib0m6Cckoj1K7cJkOI6CTrDh9Epco1zYLOtzs7icSgITEtJucVKNxnNLF34qG5GyxoZQ/0, createdBy=e71e2167526, createdName=ms9833658896231706, createdTime=Tue Mar 21 08:40:11 CST 2023, time=2023-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2190285, encodeId=137b21902856d, content=12月30号返修回去，投稿链接1月27显示的2个审稿人已经完成审稿，但是到今天系统一直是RRC，咋办呀？能催编辑吗？我感觉编辑都忘记了。。。太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d9892565543, createdName=12570e4cm50暂无昵称, createdTime=Fri Mar 01 08:18:28 CST 2024, time=2024-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189811, encodeId=4f6f218981181, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：炎症;巨噬细胞;骨科 经验分享：三个审稿人，每个审稿人8-10条意见，非常专业，效率很高，三个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8a02458802, createdName=12411d2dm22暂无昵称, createdTime=Wed Feb 28 09:19:40 CST 2024, time=2024-02-28, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2170197, encodeId=1dd921e019749, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：10.05投稿 10.11送审 10.26审稿人完成审稿 10.31给出大修 11.05修回 11.15审稿人完成审稿 11.16接收 11.19清样 10.22在线发表来还愿啦！效率很高的一个杂志，编辑和两位审稿人都很友好。修改后文章整体水平提升很大。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YConHRH5GCtcFEWO7xCkB10VsePH8PlzvattQoVRIQ7KJg26g6PvbkD8nE6Gsic5Nub2HzA4TsvkTQqEYUoz7pw/132, createdBy=288f2160779, createdName=liyu5975, createdTime=Wed Nov 22 11:16:56 CST 2023, time=2023-11-22, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2194365, encodeId=4820219436502, content=审稿速度:1.0 经验分享：审稿人意见“请修改文本格式，必要时使用连字符，使文章布局更加整洁易读”，这是什么意思？求指点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=884b6159465, createdName=ms5000000335651495, createdTime=Wed Mar 20 22:39:15 CST 2024, time=2024-03-20, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2194329, encodeId=c62d21943297a, content=大家知道自己的编辑是谁吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65878460096, createdName=ms9000002114823480, createdTime=Wed Mar 20 17:21:49 CST 2024, time=2024-03-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2194400, encodeId=4fed219440008, content=<a href='/topic/show?id=0d6a159920a' target=_blank style='color:#2F92EE;'>#SCI#</a>Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15992, encryptionId=0d6a159920a, topicName=SCI)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Thu Mar 21 09:05:46 CST 2024, time=2024-03-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2186259, encodeId=31eb21862594e, content=偏重的研究方向：免疫;药理学;炎症 经验分享：12.16日投稿，隔天under review，12.30第一个审稿人审回，一直到今天都木找到第二个审稿人……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04fe5219567, createdName=14778916m81暂无昵称, createdTime=Tue Feb 06 21:11:26 CST 2024, time=2024-02-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2159939, encodeId=cf6b215993935, content=9.22投稿，9.24 under review，邀请了9个审稿人，到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd58097633, createdName=ms8000001070008739, createdTime=Wed Sep 27 01:50:27 CST 2023, time=2023-09-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2182438, encodeId=a56c21824388d, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：胃癌;肿瘤免疫 经验分享：这个杂志真的好慢好慢，外审一个月，大修一个月，修回with editor一整个月，然后又送外审，十几天，RRC两周了，还没消息，等的我花都谢了。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Thu Jan 18 15:39:11 CST 2024, time=2024-01-18, status=1, ipAttribution=香港)]

2024-03-20 ms5000000335651495 来自云南省

审稿速度:1.0
经验分享：审稿人意见“请修改文本格式，必要时使用连字符，使文章布局更加整洁易读”，这是什么意思？求指点。

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2120704, encodeId=32302120e0483, content=2023-03-03投稿 03-06 with editor 03-09 under review 03-15 under review 后续有进展再来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=35, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/7xB3OdNLiaPjMD3qablwtib0m6Cckoj1K7cJkOI6CTrDh9Epco1zYLOtzs7icSgITEtJucVKNxnNLF34qG5GyxoZQ/0, createdBy=e71e2167526, createdName=ms9833658896231706, createdTime=Tue Mar 21 08:40:11 CST 2023, time=2023-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2190285, encodeId=137b21902856d, content=12月30号返修回去，投稿链接1月27显示的2个审稿人已经完成审稿，但是到今天系统一直是RRC，咋办呀？能催编辑吗？我感觉编辑都忘记了。。。太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d9892565543, createdName=12570e4cm50暂无昵称, createdTime=Fri Mar 01 08:18:28 CST 2024, time=2024-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189811, encodeId=4f6f218981181, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：炎症;巨噬细胞;骨科 经验分享：三个审稿人，每个审稿人8-10条意见，非常专业，效率很高，三个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8a02458802, createdName=12411d2dm22暂无昵称, createdTime=Wed Feb 28 09:19:40 CST 2024, time=2024-02-28, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2170197, encodeId=1dd921e019749, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：10.05投稿 10.11送审 10.26审稿人完成审稿 10.31给出大修 11.05修回 11.15审稿人完成审稿 11.16接收 11.19清样 10.22在线发表来还愿啦！效率很高的一个杂志，编辑和两位审稿人都很友好。修改后文章整体水平提升很大。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YConHRH5GCtcFEWO7xCkB10VsePH8PlzvattQoVRIQ7KJg26g6PvbkD8nE6Gsic5Nub2HzA4TsvkTQqEYUoz7pw/132, createdBy=288f2160779, createdName=liyu5975, createdTime=Wed Nov 22 11:16:56 CST 2023, time=2023-11-22, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2194365, encodeId=4820219436502, content=审稿速度:1.0 经验分享：审稿人意见“请修改文本格式，必要时使用连字符，使文章布局更加整洁易读”，这是什么意思？求指点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=884b6159465, createdName=ms5000000335651495, createdTime=Wed Mar 20 22:39:15 CST 2024, time=2024-03-20, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2194329, encodeId=c62d21943297a, content=大家知道自己的编辑是谁吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65878460096, createdName=ms9000002114823480, createdTime=Wed Mar 20 17:21:49 CST 2024, time=2024-03-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2194400, encodeId=4fed219440008, content=<a href='/topic/show?id=0d6a159920a' target=_blank style='color:#2F92EE;'>#SCI#</a>Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15992, encryptionId=0d6a159920a, topicName=SCI)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Thu Mar 21 09:05:46 CST 2024, time=2024-03-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2186259, encodeId=31eb21862594e, content=偏重的研究方向：免疫;药理学;炎症 经验分享：12.16日投稿，隔天under review，12.30第一个审稿人审回，一直到今天都木找到第二个审稿人……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04fe5219567, createdName=14778916m81暂无昵称, createdTime=Tue Feb 06 21:11:26 CST 2024, time=2024-02-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2159939, encodeId=cf6b215993935, content=9.22投稿，9.24 under review，邀请了9个审稿人，到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd58097633, createdName=ms8000001070008739, createdTime=Wed Sep 27 01:50:27 CST 2023, time=2023-09-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2182438, encodeId=a56c21824388d, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：胃癌;肿瘤免疫 经验分享：这个杂志真的好慢好慢，外审一个月，大修一个月，修回with editor一整个月，然后又送外审，十几天，RRC两周了，还没消息，等的我花都谢了。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Thu Jan 18 15:39:11 CST 2024, time=2024-01-18, status=1, ipAttribution=香港)]

2024-03-20 ms9000002114823480 来自福建省

大家知道自己的编辑是谁吗？

9 0

[GetPortalCommentsPageByObjectIdResponse(id=2120704, encodeId=32302120e0483, content=2023-03-03投稿 03-06 with editor 03-09 under review 03-15 under review 后续有进展再来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=35, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/7xB3OdNLiaPjMD3qablwtib0m6Cckoj1K7cJkOI6CTrDh9Epco1zYLOtzs7icSgITEtJucVKNxnNLF34qG5GyxoZQ/0, createdBy=e71e2167526, createdName=ms9833658896231706, createdTime=Tue Mar 21 08:40:11 CST 2023, time=2023-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2190285, encodeId=137b21902856d, content=12月30号返修回去，投稿链接1月27显示的2个审稿人已经完成审稿，但是到今天系统一直是RRC，咋办呀？能催编辑吗？我感觉编辑都忘记了。。。太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d9892565543, createdName=12570e4cm50暂无昵称, createdTime=Fri Mar 01 08:18:28 CST 2024, time=2024-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189811, encodeId=4f6f218981181, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：炎症;巨噬细胞;骨科 经验分享：三个审稿人，每个审稿人8-10条意见，非常专业，效率很高，三个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8a02458802, createdName=12411d2dm22暂无昵称, createdTime=Wed Feb 28 09:19:40 CST 2024, time=2024-02-28, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2170197, encodeId=1dd921e019749, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：10.05投稿 10.11送审 10.26审稿人完成审稿 10.31给出大修 11.05修回 11.15审稿人完成审稿 11.16接收 11.19清样 10.22在线发表来还愿啦！效率很高的一个杂志，编辑和两位审稿人都很友好。修改后文章整体水平提升很大。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YConHRH5GCtcFEWO7xCkB10VsePH8PlzvattQoVRIQ7KJg26g6PvbkD8nE6Gsic5Nub2HzA4TsvkTQqEYUoz7pw/132, createdBy=288f2160779, createdName=liyu5975, createdTime=Wed Nov 22 11:16:56 CST 2023, time=2023-11-22, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2194365, encodeId=4820219436502, content=审稿速度:1.0 经验分享：审稿人意见“请修改文本格式，必要时使用连字符，使文章布局更加整洁易读”，这是什么意思？求指点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=884b6159465, createdName=ms5000000335651495, createdTime=Wed Mar 20 22:39:15 CST 2024, time=2024-03-20, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2194329, encodeId=c62d21943297a, content=大家知道自己的编辑是谁吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65878460096, createdName=ms9000002114823480, createdTime=Wed Mar 20 17:21:49 CST 2024, time=2024-03-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2194400, encodeId=4fed219440008, content=<a href='/topic/show?id=0d6a159920a' target=_blank style='color:#2F92EE;'>#SCI#</a>Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15992, encryptionId=0d6a159920a, topicName=SCI)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Thu Mar 21 09:05:46 CST 2024, time=2024-03-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2186259, encodeId=31eb21862594e, content=偏重的研究方向：免疫;药理学;炎症 经验分享：12.16日投稿，隔天under review，12.30第一个审稿人审回，一直到今天都木找到第二个审稿人……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04fe5219567, createdName=14778916m81暂无昵称, createdTime=Tue Feb 06 21:11:26 CST 2024, time=2024-02-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2159939, encodeId=cf6b215993935, content=9.22投稿，9.24 under review，邀请了9个审稿人，到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd58097633, createdName=ms8000001070008739, createdTime=Wed Sep 27 01:50:27 CST 2023, time=2023-09-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2182438, encodeId=a56c21824388d, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：胃癌;肿瘤免疫 经验分享：这个杂志真的好慢好慢，外审一个月，大修一个月，修回with editor一整个月，然后又送外审，十几天，RRC两周了，还没消息，等的我花都谢了。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Thu Jan 18 15:39:11 CST 2024, time=2024-01-18, status=1, ipAttribution=香港)]

2024-03-21 零零一来自广西

#SCI#Accept

10 0

[GetPortalCommentsPageByObjectIdResponse(id=2120704, encodeId=32302120e0483, content=2023-03-03投稿 03-06 with editor 03-09 under review 03-15 under review 后续有进展再来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=35, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/7xB3OdNLiaPjMD3qablwtib0m6Cckoj1K7cJkOI6CTrDh9Epco1zYLOtzs7icSgITEtJucVKNxnNLF34qG5GyxoZQ/0, createdBy=e71e2167526, createdName=ms9833658896231706, createdTime=Tue Mar 21 08:40:11 CST 2023, time=2023-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2190285, encodeId=137b21902856d, content=12月30号返修回去，投稿链接1月27显示的2个审稿人已经完成审稿，但是到今天系统一直是RRC，咋办呀？能催编辑吗？我感觉编辑都忘记了。。。太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d9892565543, createdName=12570e4cm50暂无昵称, createdTime=Fri Mar 01 08:18:28 CST 2024, time=2024-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189811, encodeId=4f6f218981181, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：炎症;巨噬细胞;骨科 经验分享：三个审稿人，每个审稿人8-10条意见，非常专业，效率很高，三个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8a02458802, createdName=12411d2dm22暂无昵称, createdTime=Wed Feb 28 09:19:40 CST 2024, time=2024-02-28, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2170197, encodeId=1dd921e019749, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：10.05投稿 10.11送审 10.26审稿人完成审稿 10.31给出大修 11.05修回 11.15审稿人完成审稿 11.16接收 11.19清样 10.22在线发表来还愿啦！效率很高的一个杂志，编辑和两位审稿人都很友好。修改后文章整体水平提升很大。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YConHRH5GCtcFEWO7xCkB10VsePH8PlzvattQoVRIQ7KJg26g6PvbkD8nE6Gsic5Nub2HzA4TsvkTQqEYUoz7pw/132, createdBy=288f2160779, createdName=liyu5975, createdTime=Wed Nov 22 11:16:56 CST 2023, time=2023-11-22, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2194365, encodeId=4820219436502, content=审稿速度:1.0 经验分享：审稿人意见“请修改文本格式，必要时使用连字符，使文章布局更加整洁易读”，这是什么意思？求指点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=884b6159465, createdName=ms5000000335651495, createdTime=Wed Mar 20 22:39:15 CST 2024, time=2024-03-20, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2194329, encodeId=c62d21943297a, content=大家知道自己的编辑是谁吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65878460096, createdName=ms9000002114823480, createdTime=Wed Mar 20 17:21:49 CST 2024, time=2024-03-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2194400, encodeId=4fed219440008, content=<a href='/topic/show?id=0d6a159920a' target=_blank style='color:#2F92EE;'>#SCI#</a>Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15992, encryptionId=0d6a159920a, topicName=SCI)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Thu Mar 21 09:05:46 CST 2024, time=2024-03-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2186259, encodeId=31eb21862594e, content=偏重的研究方向：免疫;药理学;炎症 经验分享：12.16日投稿，隔天under review，12.30第一个审稿人审回，一直到今天都木找到第二个审稿人……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04fe5219567, createdName=14778916m81暂无昵称, createdTime=Tue Feb 06 21:11:26 CST 2024, time=2024-02-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2159939, encodeId=cf6b215993935, content=9.22投稿，9.24 under review，邀请了9个审稿人，到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd58097633, createdName=ms8000001070008739, createdTime=Wed Sep 27 01:50:27 CST 2023, time=2023-09-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2182438, encodeId=a56c21824388d, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：胃癌;肿瘤免疫 经验分享：这个杂志真的好慢好慢，外审一个月，大修一个月，修回with editor一整个月，然后又送外审，十几天，RRC两周了，还没消息，等的我花都谢了。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Thu Jan 18 15:39:11 CST 2024, time=2024-01-18, status=1, ipAttribution=香港)]

2024-02-06 14778916m81暂无昵称来自广东省

偏重的研究方向：免疫;药理学;炎症
经验分享：12.16日投稿，隔天under review，12.30第一个审稿人审回，一直到今天都木找到第二个审稿人……

15 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=2120704, encodeId=32302120e0483, content=2023-03-03投稿 03-06 with editor 03-09 under review 03-15 under review 后续有进展再来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=35, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/7xB3OdNLiaPjMD3qablwtib0m6Cckoj1K7cJkOI6CTrDh9Epco1zYLOtzs7icSgITEtJucVKNxnNLF34qG5GyxoZQ/0, createdBy=e71e2167526, createdName=ms9833658896231706, createdTime=Tue Mar 21 08:40:11 CST 2023, time=2023-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2190285, encodeId=137b21902856d, content=12月30号返修回去，投稿链接1月27显示的2个审稿人已经完成审稿，但是到今天系统一直是RRC，咋办呀？能催编辑吗？我感觉编辑都忘记了。。。太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d9892565543, createdName=12570e4cm50暂无昵称, createdTime=Fri Mar 01 08:18:28 CST 2024, time=2024-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189811, encodeId=4f6f218981181, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：炎症;巨噬细胞;骨科 经验分享：三个审稿人，每个审稿人8-10条意见，非常专业，效率很高，三个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8a02458802, createdName=12411d2dm22暂无昵称, createdTime=Wed Feb 28 09:19:40 CST 2024, time=2024-02-28, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2170197, encodeId=1dd921e019749, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：10.05投稿 10.11送审 10.26审稿人完成审稿 10.31给出大修 11.05修回 11.15审稿人完成审稿 11.16接收 11.19清样 10.22在线发表来还愿啦！效率很高的一个杂志，编辑和两位审稿人都很友好。修改后文章整体水平提升很大。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YConHRH5GCtcFEWO7xCkB10VsePH8PlzvattQoVRIQ7KJg26g6PvbkD8nE6Gsic5Nub2HzA4TsvkTQqEYUoz7pw/132, createdBy=288f2160779, createdName=liyu5975, createdTime=Wed Nov 22 11:16:56 CST 2023, time=2023-11-22, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2194365, encodeId=4820219436502, content=审稿速度:1.0 经验分享：审稿人意见“请修改文本格式，必要时使用连字符，使文章布局更加整洁易读”，这是什么意思？求指点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=884b6159465, createdName=ms5000000335651495, createdTime=Wed Mar 20 22:39:15 CST 2024, time=2024-03-20, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2194329, encodeId=c62d21943297a, content=大家知道自己的编辑是谁吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65878460096, createdName=ms9000002114823480, createdTime=Wed Mar 20 17:21:49 CST 2024, time=2024-03-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2194400, encodeId=4fed219440008, content=<a href='/topic/show?id=0d6a159920a' target=_blank style='color:#2F92EE;'>#SCI#</a>Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15992, encryptionId=0d6a159920a, topicName=SCI)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Thu Mar 21 09:05:46 CST 2024, time=2024-03-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2186259, encodeId=31eb21862594e, content=偏重的研究方向：免疫;药理学;炎症 经验分享：12.16日投稿，隔天under review，12.30第一个审稿人审回，一直到今天都木找到第二个审稿人……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04fe5219567, createdName=14778916m81暂无昵称, createdTime=Tue Feb 06 21:11:26 CST 2024, time=2024-02-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2159939, encodeId=cf6b215993935, content=9.22投稿，9.24 under review，邀请了9个审稿人，到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd58097633, createdName=ms8000001070008739, createdTime=Wed Sep 27 01:50:27 CST 2023, time=2023-09-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2182438, encodeId=a56c21824388d, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：胃癌;肿瘤免疫 经验分享：这个杂志真的好慢好慢，外审一个月，大修一个月，修回with editor一整个月，然后又送外审，十几天，RRC两周了，还没消息，等的我花都谢了。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Thu Jan 18 15:39:11 CST 2024, time=2024-01-18, status=1, ipAttribution=香港)]

2023-09-27 ms8000001070008739 来自上海

9.22投稿，9.24 under review，邀请了9个审稿人，到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……

17 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2120704, encodeId=32302120e0483, content=2023-03-03投稿 03-06 with editor 03-09 under review 03-15 under review 后续有进展再来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=35, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/7xB3OdNLiaPjMD3qablwtib0m6Cckoj1K7cJkOI6CTrDh9Epco1zYLOtzs7icSgITEtJucVKNxnNLF34qG5GyxoZQ/0, createdBy=e71e2167526, createdName=ms9833658896231706, createdTime=Tue Mar 21 08:40:11 CST 2023, time=2023-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2190285, encodeId=137b21902856d, content=12月30号返修回去，投稿链接1月27显示的2个审稿人已经完成审稿，但是到今天系统一直是RRC，咋办呀？能催编辑吗？我感觉编辑都忘记了。。。太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d9892565543, createdName=12570e4cm50暂无昵称, createdTime=Fri Mar 01 08:18:28 CST 2024, time=2024-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189811, encodeId=4f6f218981181, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：炎症;巨噬细胞;骨科 经验分享：三个审稿人，每个审稿人8-10条意见，非常专业，效率很高，三个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8a02458802, createdName=12411d2dm22暂无昵称, createdTime=Wed Feb 28 09:19:40 CST 2024, time=2024-02-28, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2170197, encodeId=1dd921e019749, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫;炎症 经验分享：10.05投稿 10.11送审 10.26审稿人完成审稿 10.31给出大修 11.05修回 11.15审稿人完成审稿 11.16接收 11.19清样 10.22在线发表来还愿啦！效率很高的一个杂志，编辑和两位审稿人都很友好。修改后文章整体水平提升很大。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YConHRH5GCtcFEWO7xCkB10VsePH8PlzvattQoVRIQ7KJg26g6PvbkD8nE6Gsic5Nub2HzA4TsvkTQqEYUoz7pw/132, createdBy=288f2160779, createdName=liyu5975, createdTime=Wed Nov 22 11:16:56 CST 2023, time=2023-11-22, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2194365, encodeId=4820219436502, content=审稿速度:1.0 经验分享：审稿人意见“请修改文本格式，必要时使用连字符，使文章布局更加整洁易读”，这是什么意思？求指点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=884b6159465, createdName=ms5000000335651495, createdTime=Wed Mar 20 22:39:15 CST 2024, time=2024-03-20, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2194329, encodeId=c62d21943297a, content=大家知道自己的编辑是谁吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65878460096, createdName=ms9000002114823480, createdTime=Wed Mar 20 17:21:49 CST 2024, time=2024-03-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2194400, encodeId=4fed219440008, content=<a href='/topic/show?id=0d6a159920a' target=_blank style='color:#2F92EE;'>#SCI#</a>Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15992, encryptionId=0d6a159920a, topicName=SCI)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Thu Mar 21 09:05:46 CST 2024, time=2024-03-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2186259, encodeId=31eb21862594e, content=偏重的研究方向：免疫;药理学;炎症 经验分享：12.16日投稿，隔天under review，12.30第一个审稿人审回，一直到今天都木找到第二个审稿人……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04fe5219567, createdName=14778916m81暂无昵称, createdTime=Tue Feb 06 21:11:26 CST 2024, time=2024-02-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2159939, encodeId=cf6b215993935, content=9.22投稿，9.24 under review，邀请了9个审稿人，到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd58097633, createdName=ms8000001070008739, createdTime=Wed Sep 27 01:50:27 CST 2023, time=2023-09-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2182438, encodeId=a56c21824388d, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：胃癌;肿瘤免疫 经验分享：这个杂志真的好慢好慢，外审一个月，大修一个月，修回with editor一整个月，然后又送外审，十几天，RRC两周了，还没消息，等的我花都谢了。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Thu Jan 18 15:39:11 CST 2024, time=2024-01-18, status=1, ipAttribution=香港)]

2024-01-18 ms9000001327347856 来自香港

审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：胃癌;肿瘤免疫
经验分享：这个杂志真的好慢好慢，外审一个月，大修一个月，修回with editor一整个月，然后又送外审，十几天，RRC两周了，还没消息，等的我花都谢了。。。。。

243 7

展开7条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务